<DOC>
	<DOCNO>NCT00122785</DOCNO>
	<brief_summary>The purpose study determine whether single intramuscular injection dexamethasone decrease duration symptom acute bronchiolitis young child .</brief_summary>
	<brief_title>Single Injection Dexamethasone Acute Bronchiolitis Young Children</brief_title>
	<detailed_description>Acute bronchiolitis infection lower respiratory tract cause inflammation small airway , lead bronchiolar obstruction . Corticosteroids frequently prescribe anti-inflammatory drug . The usefulness corticosteroid disease remain controversial , despite many randomize controlled trial ( RCTs ) . Recently , meta-analysis systemic review show significant improvement clinical symptom , length hospital stay duration symptom child disease treatment various regimen systemic corticosteroid . Dexamethasone long act corticosteroid biologic half-life range 36-72 hour . A single dose dexamethasone standard recommendation treatment croup similar pathophysiology without evidence adverse effect . Furthermore , previous report single dosage form dexamethasone treatment acute bronchiolitis young child .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis , Viral</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Aged 4 week 24 month Has first episode wheeze within 7 day Has evidence viral infection Requires hospital admission ; criterion admission include one following : age &lt; 3 month ; respiratory rate &gt; 60 breaths/minute age &lt; 12 month 50 breaths/minute &gt; equal 12 month ; oxygen saturation room air &lt; 95 % apathy refuse feed . Initial admission intensive care unit Initial requirement endotracheal intubation mechanical ventilation A previous history intubation A known history asthma response first dose beta2 agonist nebulization A history prematurity A history bronchopulmonary dysplasia chronic lung disease Underlying congenital heart disease immunodeficiency Receives treatment form corticosteroid within 2 week Has contraindication corticosteroid treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>February 2005</verification_date>
	<keyword>bronchiolitis</keyword>
	<keyword>wheeze</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>young child</keyword>
</DOC>